Staphylococcus aureus vaccine - Affinivax
Alternative Names: MAPS Staphylococcus aureus vaccine - AffinivaxLatest Information Update: 28 May 2024
At a glance
- Originator Affinivax
- Class Bacterial vaccines; Conjugate vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Staphylococcal infections
Highest Development Phases
- No development reported Staphylococcal infections